Jiangsu Morning Brand Pharmaceutical Group Co., Ltd.
-
Founded in:
1996-05-28 -
Country:
China -
Address:
No. 666, Beijing East Road, Haimen District, Nantong City, Jiangsu Province -
Tax NO.:
913206001388073171 -
Registered Funds:
55 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Versicolor intracellular sugar peptide |
1. Enhance the function of the reticuloendothelial system, increase the concentration of induced serum interferon in mice, activate the function of leukocytes, promote the production of specific hemolysin antibodies, improve and restore normal cellular immune function; 2. It has a significant protective effect on acute liver damage caused by D-galactosamine and carbon tetrachloride, inhibits the increase of SGP and fatty degeneration of liver cells, and avoids focal necrosis; 3. Kills Ehrlich ascites cancer cells, enhances the effect of anticancer drugs, and inhibits tumor angiogenesis and breast cancer growth; 4. Activates the body's defense immune system, has nonspecific anti-infection and anti-shock effects, reduces the mortality caused by various bacterial and viral infections, and prolongs survival time.
More
1. Enhance the function of the reticuloendothelial system, increase the concentration of induced serum interferon in mice, activate the function of leukocytes, promote the production of specific hemolysin antibodies, improve and restore normal cellular immune function; 2. It has a significant protective effect on acute liver damage caused by D-galactosamine and carbon tetrachloride, inhibits the increase of SGP and fatty degeneration of liver cells, and avoids focal necrosis; 3. Kills Ehrlich ascites cancer cells, enhances the effect of anticancer drugs, and inhibits tumor angiogenesis and breast cancer growth; 4. Activates the body's defense immune system, has nonspecific anti-infection and anti-shock effects, reduces the mortality caused by various bacterial and viral infections, and prolongs survival time. |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Ginkgo biloba extract |
|
90045-36-6 | 4 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Monopotassium glycyrrhizate |
1. Anti-inflammatory effect: (1) Anti-allergic effect. Glycyrrhizin has anti-allergic effects such as inhibiting local allergic necrosis reaction (Arthus Phenomenon) and inhibiting Schwartzman Phenomenon in rabbits. For corticosteroids, it enhances the hormone's inhibitory effect on stress response and antagonizes the hormone's anti-granulation and thymic atrophy effects. It has no effect on the exudation of hormones. (2) Inhibitory effect on arachidonic acid metabolic enzymes. Glycyrrhizin can directly bind to phospholipase A2 and lipoxygenase, selectively inhibiting the phosphorylation of these enzymes and inhibiting their activation. 2. Immunomodulatory effect: (1) Regulatory effect on T cell activation; (2) Inducing effect on interferon; (3) Activating NK cells; (4) Promoting the differentiation of extrathymic T lymphocytes. 3. Inhibitory effect on experimental hepatocyte damage: In the rat hepatocyte cell line cultured in vitro, glycyrrhizin inhibited hepatocyte damage caused by carbon tetrachloride. 4. Inhibit virus proliferation and inactivate viruses: In the MHV infection experiment in mice, administration of glycyrrhizin can prolong their survival days. In the vaccinia virus pox prevention experiment in rabbits, it has an effect of preventing pox. In the in vitro experimental system, the proliferation of herpes viruses and the inactivation of viruses were also observed.
More
1. Anti-inflammatory effect: (1) Anti-allergic effect. Glycyrrhizin has anti-allergic effects such as inhibiting local allergic necrosis reaction (Arthus Phenomenon) and inhibiting Schwartzman Phenomenon in rabbits. For corticosteroids, it enhances the hormone's inhibitory effect on stress response and antagonizes the hormone's anti-granulation and thymic atrophy effects. It has no effect on the exudation of hormones. (2) Inhibitory effect on arachidonic acid metabolic enzymes. Glycyrrhizin can directly bind to phospholipase A2 and lipoxygenase, selectively inhibiting the phosphorylation of these enzymes and inhibiting their activation. 2. Immunomodulatory effect: (1) Regulatory effect on T cell activation; (2) Inducing effect on interferon; (3) Activating NK cells; (4) Promoting the differentiation of extrathymic T lymphocytes. 3. Inhibitory effect on experimental hepatocyte damage: In the rat hepatocyte cell line cultured in vitro, glycyrrhizin inhibited hepatocyte damage caused by carbon tetrachloride. 4. Inhibit virus proliferation and inactivate viruses: In the MHV infection experiment in mice, administration of glycyrrhizin can prolong their survival days. In the vaccinia virus pox prevention experiment in rabbits, it has an effect of preventing pox. In the in vitro experimental system, the proliferation of herpes viruses and the inactivation of viruses were also observed. |
42294-03-1 | 2 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Fleroxacin |
This product is a quinolone antibacterial drug, which has strong antibacterial effect on Gram-negative bacteria, including Escherichia coli, Klebsiella pneumoniae, Proteus, Salmonella typhi, Salmonella paratyphi, Shigella, Enterobacter cloacae, Enterobacter aerogenes, Citrobacter, Serratia marcescens, Pseudomonas aeruginosa, Neisseria meningitidis, Haemophilus influenzae, Moracata, Legionella pneumophila, Neisseria gonorrhoeae, etc. It also has moderate antibacterial effect on Gram-positive cocci such as Staphylococcus and hemolytic Streptococcus. The mechanism of action of this product is to inhibit the bacterial DNA gyrase and thus kill the bacteria.
More
This product is a quinolone antibacterial drug, which has strong antibacterial effect on Gram-negative bacteria, including Escherichia coli, Klebsiella pneumoniae, Proteus, Salmonella typhi, Salmonella paratyphi, Shigella, Enterobacter cloacae, Enterobacter aerogenes, Citrobacter, Serratia marcescens, Pseudomonas aeruginosa, Neisseria meningitidis, Haemophilus influenzae, Moracata, Legionella pneumophila, Neisseria gonorrhoeae, etc. It also has moderate antibacterial effect on Gram-positive cocci such as Staphylococcus and hemolytic Streptococcus. The mechanism of action of this product is to inhibit the bacterial DNA gyrase and thus kill the bacteria. |
79660-72-3 | 6 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Fleroxacin |
This product is a quinolone antibacterial drug, which has strong antibacterial effect on Gram-negative bacteria, including Escherichia coli, Klebsiella pneumoniae, Proteus, Salmonella typhi, Salmonella paratyphi, Shigella, Enterobacter cloacae, Enterobacter aerogenes, Citrobacter, Serratia marcescens, Pseudomonas aeruginosa, Neisseria meningitidis, Haemophilus influenzae, Moracata, Legionella pneumophila, Neisseria gonorrhoeae, etc. It also has moderate antibacterial effect on Gram-positive cocci such as Staphylococcus and hemolytic Streptococcus. The mechanism of action of this product is to inhibit the bacterial DNA gyrase and thus kill the bacteria.
More
This product is a quinolone antibacterial drug, which has strong antibacterial effect on Gram-negative bacteria, including Escherichia coli, Klebsiella pneumoniae, Proteus, Salmonella typhi, Salmonella paratyphi, Shigella, Enterobacter cloacae, Enterobacter aerogenes, Citrobacter, Serratia marcescens, Pseudomonas aeruginosa, Neisseria meningitidis, Haemophilus influenzae, Moracata, Legionella pneumophila, Neisseria gonorrhoeae, etc. It also has moderate antibacterial effect on Gram-positive cocci such as Staphylococcus and hemolytic Streptococcus. The mechanism of action of this product is to inhibit the bacterial DNA gyrase and thus kill the bacteria. |
79660-72-3 | 6 |